Novartis granted orphan status for treatment of diffuse large B-cell lymphoma
Novartis' Afinitor was granted FDA orphan designation as a treatment of diffuse large B-cell lymphoma, according to a post to the regulator's website.
Advertisement
Recommended Stories
Why Nvidia Stock Plunged 10% Today
Super Micro Computer's lack of a preliminary earnings report led to a bloodbath in the sector.
Motley Fool•The Headache at the End of the Costco Gold Rush
Costco made buying a gold bar as simple as tossing it in a shopping cart. Adam Xi, 33 years old, called five different dealers to get a price he could accept for the gold bar he bought at Costco in October. Costco shoppers are spending as much as $200 million monthly on gold, according to a Wells Fargo estimate.
The Wall Street Journal•Don’t Make This Inheritance Mistake. It Could Cost Your Loved Ones Big Time.
Suppose you have a $3 million brokerage account and a $3 million tax-deferred retirement account. Your daughter, who already is in a high tax bracket under her salary, will pay tax on every dollar she pulls out of the retirement account. The Salvation Army, meanwhile, won’t pay taxes in either case—whether it receives the retirement account or the brokerage account.
Barrons.com•Welcome to 'peak boomer' era: A wave of retirees is about to blow through their savings and cling to Social Security to stay afloat
While more older boomers tend to have a pension, a looming wave of younger retirees are about to strain the economy and Social Security.
Business Insider•Why Did Arm, Intel, AMD, and Nvidia Crash on Friday?
The buying opportunity for semiconductor stock investors might be around the corner.
Motley Fool•Forget Nvidia and Intel: This Stock Could Be the Biggest Winner of Their New Chip Launches
This company has been around for decades, but the recent AI boom has supercharged growth.
Motley Fool•Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
If you are looking to buy good dividend stocks to hold for years to come, this varied trio should be atop your list today.
Motley Fool•Bitcoin Holds Steady After ‘Halving’ Concludes
Crypto bulls are hoping that Bitcoin’s ‘halving’ will be a catalyst for further gains in the world’s largest cryptocurrency.
Barrons.com•Sell in May and Go Away? Absolutely Not -- 2 Stocks You'll Want to Buy Instead
Seasonality is a factor in the stock market, but it isn't a reason to abandon your long-term investment strategy.
Motley Fool•2 S&P 500 Dividend Stocks With Yields Above 6% That You Can Buy With $100
You don't have to be rich to get your money to start working for you.
Motley Fool•